There is immense potential for novel molecular technology to revolutionise medical care. In this presentation Mr Babar Vaqas, Neurosurgeon from the Takats lab at Imperial College London, will outline the many facets of surgical mass spectrometry and its capacity to influence the surgical decisions of the future. Mr Vaqas will focus on the difficulties encountered when operating and treating brain cancer, and how the advent of personalised medicine may provide the badly needed solutions needed for patients who may not survive longer than a few months.